Comparison of the sodium dependency of uptake of meta-lodobenzylguanidine and norepinephrine into cultured bovine adrenomedullary cells
- PMID: 6493209
Comparison of the sodium dependency of uptake of meta-lodobenzylguanidine and norepinephrine into cultured bovine adrenomedullary cells
Abstract
Radioiodinated meta-iodobenzylguanidine (MIBG), a scintigraphic agent used for the detection of human pheochromocytomas, is thought to utilize the same uptake and retention mechanism(s) as norepinephrine (NE). Using cultured bovine adrenomedullary cells, we compared the mechanism(s) of uptake of MIBG to that of NE. Two different uptake systems were identified. NE and MIBG were taken up by a sodium-dependent system that was characterized by: 1) temperature dependency; 2) high affinity: Km of 1.22 +/- 0.12 microM for MIBG and 1.41 +/- 0.50 microM for NE; 3) low capacity: Vm (picomoles/10(6) cells/10 min) of 64.3 +/- 3.3 for MIBG and 36.6 +/- 7.2 for NE; 4) saturability; 5) ouabain sensitivity; and 6) energy dependency. However, NE and MIBG also were taken up by a temperature-dependent, sodium-independent, apparently unsaturable, and energy-independent system. The sodium-dependent uptake system fulfills many of the criteria for Uptake1 whereas the sodium-independent uptake system is most likely a passive diffusion process. NE uptake proceeded predominantly by the sodium-dependent process. Uptake of MIBG occurred by both pathways at low concentrations, but at high concentrations (greater than 10 microM) uptake was predominantly (75 to 100%) by the sodium-independent process. Inhibition studies suggest that MIBG and NE are transported by the same carrier involved in the sodium-dependent system. Scintiscans of the human adrenals and pheochromocytomas appear to reflect uptake of [131I]MIBG by the sodium-dependent system.
Similar articles
-
Sodium dependency of uptake of norepinephrine and m-iodobenzylguanidine into cultured human pheochromocytoma cells: evidence for uptake-one.Cancer Res. 1987 Aug 1;47(15):3920-8. Cancer Res. 1987. PMID: 3607739
-
Effect of uptake-one inhibitors on the uptake of norepinephrine and metaiodobenzylguanidine.J Nucl Med. 1985 Aug;26(8):897-907. J Nucl Med. 1985. PMID: 3162008
-
Active uptake and extravesicular storage of m-iodobenzylguanidine in human neuroblastoma SK-N-SH cells.Cancer Res. 1989 Jun 1;49(11):2941-4. Cancer Res. 1989. PMID: 2720653
-
Radiation quality-dependent bystander effects elicited by targeted radionuclides.J Pharm Pharmacol. 2008 Aug;60(8):951-8. doi: 10.1211/jpp.60.8.0002. J Pharm Pharmacol. 2008. PMID: 18644188 Review.
-
Radioiodinated metaiodobenzylguanidine (MIBG): radiochemistry, biology, and pharmacology.Semin Nucl Med. 2011 Sep;41(5):324-33. doi: 10.1053/j.semnuclmed.2011.05.003. Semin Nucl Med. 2011. PMID: 21803182 Review.
Cited by
-
Myocardial uptake of meta-[123I]-iodobenzylguanidine [( 123I]-MIBG) in patients with myocardial infarct.Eur J Nucl Med. 1989;15(9):624-8. doi: 10.1007/BF00256942. Eur J Nucl Med. 1989. PMID: 2574671
-
A 4-methyl-substituted meta-iodobenzylguanidine analogue with prolonged retention in human neuroblastoma cells.Eur J Nucl Med Mol Imaging. 2004 Oct;31(10):1362-70. doi: 10.1007/s00259-004-1596-8. Epub 2004 Jun 16. Eur J Nucl Med Mol Imaging. 2004. PMID: 15205923
-
Effect of adrenergic receptor ligands on metaiodobenzylguanidine uptake and storage in neuroblastoma cells.Eur J Nucl Med. 1997 May;24(5):538-43. doi: 10.1007/BF01267686. Eur J Nucl Med. 1997. PMID: 9142735
-
Fluorodeoxyglucose cell incorporation as an index of cell proliferation: evaluation of accuracy in cell culture.Eur J Nucl Med. 1993 Nov;20(11):1084-8. doi: 10.1007/BF00173487. Eur J Nucl Med. 1993. PMID: 7507044
-
Interaction of metaiodobenzylguanidine with cardioactive drugs: an in vitro study.Eur J Nucl Med. 1996 May;23(5):546-9. doi: 10.1007/BF00833390. Eur J Nucl Med. 1996. PMID: 8698060